Decoy Therapeutics is trading approximately 6% down today at $5.58 as investors react to the company's recently filed Form S-1 registering the resale of up to 3.77 million shares.
- The registration is tied to warrants issued during a June private placement and is accompanied by a going-concern warning regarding the company's financial outlook.
- The stock has seen significant volatility following its recent financing, with broader biotech sector weakness and risk-off sentiment adding further downward pressure.